Genetic role of CYP4A11 polymorphisms in the risk of developing cardiovascular and cerebrovascular diseases

Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases

(2018) Tao Zhang et al.   BMC Cardiovascular Disorders

Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats

(2016) Šárka Jíchová et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Interaction BetweenCYP4F2rs2108622 andCPY4A11rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level

(2016) Duanxiu Liao et al.   Genetic Testing and Molecular Biomarkers

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

(2016) Alexandra Montagner et al.   GUT

Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke

(2016) Hui Huang et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury

(2015) Y. Muroya et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Association of a CYP4A11 polymorphism and hypertension in the Mongolian and Han populations of China

(2014) J.Q. Liang et al.   GENETICS AND MOLECULAR RESEARCH

CYP4A11 gene T8590C polymorphism is associated with essential hypertension in the male western Chinese Han population

(2013) Hong Yang et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat

(2013) Kathleen M. Lukaszewicz et al.   CLINICAL SCIENCE

Genetic Associations with Hypertension: Meta-Analyses of Six Candidate Genetic Variants

(2013) Cheng Zhang et al.   Genetic Testing and Molecular Biomarkers

N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress

(2013) Giuseppina Mattace Raso et al.   PHARMACOLOGICAL RESEARCH

Association between the CYP4A11 T8590C Variant and Essential Hypertension: New Data from Han Chinese and a Meta-Analysis

(2013) Hua-Cheng Yan et al.   PLoS One

A Novel Polymorphism of the CYP4A11 Gene is Associated With Coronary Artery Disease

(2012) Zhenyan Fu et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China

(2012) Zhenyan Fu et al.   GENE

CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow

(2011) Jonathan S. Williams et al.   JOURNAL OF HYPERTENSION

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases

(2010) Beshay N.M. Zordoky et al.   PHARMACOLOGY & THERAPEUTICS

A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men

(2009) Zhenyan Fu et al.   JOURNAL OF HYPERTENSION

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Cytochrome P450 ω-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion

(2008) Xiaojun Lv et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A Polymorphism Regulates CYP4A11 Transcriptional Activity and Is Associated With Hypertension in a Japanese Population

(2008) Ken Sugimoto et al.   HYPERTENSION

The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure

(2008) Cristiano Fava et al.   HYPERTENSION

The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension

(2008) Cheryl L. Laffer et al.   HYPERTENSION

A Single Nucleotide Polymorphism in the CYP4F2 but not CYP4A11 Gene Is Associated With Increased 20-HETE Excretion and Blood Pressure

(2008) Natalie C. Ward et al.   HYPERTENSION